Physician profile
Lori Lambert
NPI 1710999651
$883.29
in general payments reported to CMS, 2019-2025
14 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.23 · 2022: $63.50 · 2023: $244 · 2024: $110 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Long Term Medical Supply Or Device Loan: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.56 |
| Long Term Medical Supply Or Device Loan | $148.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $253.71 | 2021-2025 | |
| Baxter Healthcare | $148.00 | 2025 | Hillrom - Oae Hearing Screener |
| Merck Sharp & Dohme LLC | $104.46 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $76.39 | 2023-2025 | Bexsero, Pediarix, Penmenvy |
| Seqirus USA INC | $65.69 | 2022-2025 | Flucelvax |
| Alk-Abello, INC | $61.98 | 2025 | Neffy, Odactra, Grastek |
| Neos Therapeutics, LP | $38.93 | 2023-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Sanofi Pasteur INC. | $29.38 | 2023 | |
| Kyowa Kirin, INC. | $27.95 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.71 | 2021 | |
| Exact Sciences Corporation | $15.80 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $15.47 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $14.72 | 2025 | Kristalose |
| Abbvie INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.